Another hospital permitted to use ivermectin as Covid-19 drug

ANOTHER hospital has been granted a compassionate special permit for the use of antiparasitic drug ivermectin as treatment for coronavirus disease 2019 (Covid-19).

In a virtual press briefing Friday, April 16, 2021, Food and Drug Administration (FDA) Director General Eric Domingo said the permit allows the hospital to secure one drug per 100 patients.

He said the two hospitals that were granted the permit are expected to closely monitor and regularly report on the status of their patients.

The two hospitals are also accountable for any adverse effects of the use of ivermectin.

Domingo did not name the two hospitals.

He reiterated that there have been no scientifically proven positive effects of ivermectin on Covid-19 patients.

"The conclusion, so far, by the experts is that there is insufficient evidence to recommend the use of ivermectin against Covid-19," said Domingo.

Ivermectin is approved in the Philippines as antiparasitic treatment for animals. It is not approved for commercial distribution as Covid-19 treatment. (HDT / SunStar Philippines)


SunStar website welcomes friendly debate, but comments posted on this site do not necessarily reflect the views of the SunStar management and its affiliates. SunStar reserves the right to delete, reproduce or modify comments posted here without notice. Posts that are inappropriate will automatically be deleted.

Forum rules:

Do not use obscenity. Some words have been banned. Stick to the topic. Do not veer away from the discussion. Be coherent. Do not shout or use CAPITAL LETTERS!